Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-05-22
2007-05-22
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S556000
Reexamination Certificate
active
10276646
ABSTRACT:
Compound corresponding to the general formula (I)in which X represents an oxygen or sulphur atom or an NH group and R1, R2, R3and R4each represent a hydrogen or halogen atom or a nitro, amino, trifluoromethyl, trifluoroalkoxy, cyano, hydroxyl, (C1–C6)alkyl, (C1–C6)alkoxy or phenyl group.Application in therapeutics.
REFERENCES:
patent: 5478939 (1995-12-01), Trybulski et al.
patent: 6407095 (2002-06-01), Lochead et al.
patent: 6809094 (2004-10-01), O'Neill et al.
patent: 2002/0086871 (2002-07-01), O'Neill et al.
patent: 0307140 (1989-03-01), None
patent: WO 00/34279 (2000-06-01), None
Galli Frederic
Lochead Alistair
Samson Axelle
Gupta Balaram
Kifle Bruck
Sanofi-aventis
LandOfFree
1,4-diazabicyclo[3.2.2]nonabenzoxazole, -benzothiazole and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,4-diazabicyclo[3.2.2]nonabenzoxazole, -benzothiazole and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,4-diazabicyclo[3.2.2]nonabenzoxazole, -benzothiazole and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3743005